Skip to main content
Premium Trial:

Request an Annual Quote

Biodesix Closes $8.3M Financing Round

NEW YORK (GenomeWeb News) – Biodesix today said that it has closed an $8.3 million Series E round of private financing.

The Boulder, Colo.-based molecular diagnostics firm said that new funds accounted for $4.3 million of the financing round, while the remaining $4 million came from the conversion of a convertible note. It said that all of the funds came from existing shareholders in the firm.

Biodesix plans to use the funding to support ongoing development of its technology platform and to expand sales and marketing efforts for its first product, the VeriStrat proteomic biomarker test, which is intended to help physicians guide therapy for patients with advanced non-small cell lung cancer.

In June the firm announced that it had secured Medicare coverage for the VeriStrat test.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.